Case Study Report BRAIN INITIATIVE

Total Page:16

File Type:pdf, Size:1020Kb

Case Study Report BRAIN INITIATIVE Mission-oriented R&I policies: In-depth case studies Case Study Report BRAIN INITIATIVE (US) Eva Arrilucea, Hanna Kuittinen February 2018 Case Study Report: Brain Initiative (United States) European Commission Directorate-General for Research and Innovation Directorate A — Policy Development and Coordination Unit A.6 — Open Data Policy and Science Cloud Contact Arnold Weiszenbacher E-mail [email protected] [email protected] European Commission B-1049 Brussels Manuscript completed in February 2018. This document has been prepared for the European Commission however it reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. More information on the European Union is available on the internet (http://europa.eu). Luxembourg: Publications Office of the European Union, 2017 PDF ISBN 978-92-79-80162-4 doi:10.2777/1986 KI-01-18-153-EN-N © European Union, 2018. Reuse is authorised provided the source is acknowledged. The reuse policy of European Commission documents is regulated by Decision 2011/833/EU (OJ L 330, 14.12.2011, p. 39). For any use or reproduction of photos or other material that is not under the EU copyright, permission must be sought directly from the copyright holders. Brain Initiative 2 EUROPEAN COMMISSION Mission-oriented R&I policies: In-depth case studies Case Study Report Brain Initiative (United States) Eva Arrilucea Hanna Kuittinen A Study coordinated by the Joint Institute for Innovation Policy February 2018 Directorate-General for Research and Innovation Table of Contents 1 Summary of the case study ................................................................................... 1 2 Context and objectives of the initiative ................................................................... 4 2.1 Contextual factors and origins of initiative ....................................................... 4 2.2 Strategic and operative objectives and milestones of the initiative ..................... 7 3 Resources and management .................................................................................. 9 3.1 Governance and management model .............................................................. 9 3.2 Financing model ......................................................................................... 10 3.3 Key actors and key technologies and platforms involved in the initiative ........... 13 3.4 Monitoring system and evaluation of the initiatives ........................................ 16 3.5 Level and type of citizen engagement in the initiative ..................................... 16 4 Policy instruments and wider policy-mix used for implementing the initiative ............. 17 4.1 Description of the R&I policy instruments used for implementing of the initiative ............................................................................................................... 17 4.2 Connection with other policies ..................................................................... 21 4.3 Key turning points of the initiative and policy adaptation measures .................. 24 5 Realised or expected outputs, outcomes and impacts ............................................. 26 5.1 Outputs and New Instruments ..................................................................... 26 5.2 Outcomes ................................................................................................. 26 5.3 Impacts .................................................................................................... 26 5.4 Summary of the key indicators. ................................................................... 27 6 Conclusions and lessons learned .......................................................................... 29 6.1 Identification and assessment of key strengths and weaknesses of the initiative 29 6.2 Lessons learned and key messages for European R&I policy ............................ 29 References ................................................................................................................. 31 1 Summary of the case study This document analyses the case study of mission-oriented R&I policy initiatives in the field of BRAIN studies and more concretely, the US BRAIN Initiative. The following table describes the main components of the case study: BRAIN INITIATIVE Title: The Brain Initiative Country: USA Thematic area: Health Objective(s): The Brain Initiative seeks to deepen understanding of the inner workings of the human mind and to improve how we treat, prevent, and cure disorders of the brain. Main Governing Body Private-Public Partnership Timeline: 2013-2025 Budget: USD 1.36 billion (public and private funding from 2013 to 2016) and USD 1.5 billion (part of public funding estimated from 2017 to 2025). Brief description of the On April 2, 2013, President Obama launched the BRAIN Initiative as case (250 words) part of a broader White House Neuroscience Initiative to “accelerate the development and application of new technologies that will enable researchers to produce dynamic pictures of the brain that show how individual brain cells and complex neural circuits interact at the speed of thought.” The challenge is to map the circuits of the brain, measure the fluctuating patterns of electrical and chemical activity flowing within those circuits, and understand how their interplay creates our unique cognitive and behavioural capabilities Implementation and The BRAIN Initiative is a public-private partnership including organisation (a brief National Institutes of Health NIH, National Science Foundation NSF, description of the Defense Advanced Research Projects Agency DARPA, Intelligence governance and policy Advanced Research Projects Activity IARPA, Food and Drug instruments used) Administration FDA and several private foundations, institutes, universities, companies and international partners. Observed / expected • Since the beginning of BRAIN Initiative, there are almost 300 outputs, outcomes, and publications classified in seven research categories: cell types, circuit impacts diagrams, monitor neural activity, interventional tools, theory and data analysis tools, human neuroscience and integrated approaches. • New tools and technologies. In general, technologies that are emerging from BRAIN Initiative are diverse and range from transgenic animals to sophisticated instrumentation to computational tools. Some examples are: DREADD (Designer Receptor Exclusively Activated by a Designer Drug) technology, to experimentally control circuits in animal’s brains in order to understand their function; optogenetics, a technique that allows researchers to control neuronal activity with light; miniature fluorescence microscopes, a new technology to record from thousands of neurons simultaneously; a neuroprosthetic device that translates “thoughts” into movement; diagrams ranging in scale; Brainbow, to colour neurons with fluorescent dye; CLARITY, a tissue- preservation method; photoacoustic imaging, a technique that blends the speed of precision of light with the penetrating ability of sound to interrogate neural activity; Z-brain, an open-source anatomical atlas of the entire zebrafish brain; miniaturised and highly sensitive electrophysiology and optical imaging instruments; improvements in functional magnetic resonance imaging (fMRI) • New platforms. The International Brain Station, a virtual platform for collaboration and data sharing for neuroscientists worldwide, Neurodata Without Borders, another platform to share physiological data, NeuroNex, a National Research Infrastructure for Neuroscience. • 306 publications Brain Initiative 1 BRAIN INITIATIVE • BRAIN Initiative has inspired similar large-scale brain research projects around the world, including Japan, Australia, Canada, China, South Korea and Israel. Main elements of mission-oriented R&I initiative: 1 Directionality: YES. Neurological disorders are one of the main causes of death over the world and entails a substantial and increased cost in the US. Intentionality: YES. The initiative has specific and well-articulated targets: • Accelerate the development and application of new neurotechnologies; • Enable researchers to produce a dynamic picture of the brain functioning in real time; • Explore how the brain records, processes, uses, stores, and retrieves vast quantities of information; • Shed light on the complex links between brain function and behaviour, incorporating new theories and computational models; • Help bring safe and effective products to patients and consumers. Clearly set timeline and YES. The initiative has defined scientific milestones with clear milestones: horizons: • Discovering diversity; • Maps at multiple scales; • The brain in action; • Demonstrating causality; • Identifying fundamental principles; • Advancing human neuroscience; • From BRAIN Initiative to the brain. Mobilises public and YES. The BRAIN Initiative is a public-private partnership including private investments: National Institutes of Health NIH, National Science Foundation NSF, Defense Advanced Research Projects Agency DARPA, Intelligence Advanced Research Projects Activity IARPA, Food and Drug Administration FDA and several private foundations, institutes, universities, companies and international partners. Focused on new YES. the BRAIN Initiative has a primary focus on technology knowledge creation development in the first five years (2016-2020), (basic research, TRLs 1- 4): Focused on knowledge YES.
Recommended publications
  • The Creation of Neuroscience
    The Creation of Neuroscience The Society for Neuroscience and the Quest for Disciplinary Unity 1969-1995 Introduction rom the molecular biology of a single neuron to the breathtakingly complex circuitry of the entire human nervous system, our understanding of the brain and how it works has undergone radical F changes over the past century. These advances have brought us tantalizingly closer to genu- inely mechanistic and scientifically rigorous explanations of how the brain’s roughly 100 billion neurons, interacting through trillions of synaptic connections, function both as single units and as larger ensem- bles. The professional field of neuroscience, in keeping pace with these important scientific develop- ments, has dramatically reshaped the organization of biological sciences across the globe over the last 50 years. Much like physics during its dominant era in the 1950s and 1960s, neuroscience has become the leading scientific discipline with regard to funding, numbers of scientists, and numbers of trainees. Furthermore, neuroscience as fact, explanation, and myth has just as dramatically redrawn our cultural landscape and redefined how Western popular culture understands who we are as individuals. In the 1950s, especially in the United States, Freud and his successors stood at the center of all cultural expla- nations for psychological suffering. In the new millennium, we perceive such suffering as erupting no longer from a repressed unconscious but, instead, from a pathophysiology rooted in and caused by brain abnormalities and dysfunctions. Indeed, the normal as well as the pathological have become thoroughly neurobiological in the last several decades. In the process, entirely new vistas have opened up in fields ranging from neuroeconomics and neurophilosophy to consumer products, as exemplified by an entire line of soft drinks advertised as offering “neuro” benefits.
    [Show full text]
  • BRAIN Neuroethics Working Group Meeting
    Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Neuroethics Working Group (NEWG) Meeting January 26th, 2021 On January 26th, 2021, the National Institutes of Health (NIH) Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Neuroethics Working Group (NEWG) met virtually to discuss emerging ethics themes in the BRAIN portfolio and potential future workshop topics, and revisited neuroethics themes in the BRAIN 2.0 reports. In opening remarks, John Ngai, PhD, Director of the NIH BRAIN Initiative, emphasized the importance of continuing to work towards equity, in general and in the neuroethics space. He also reminded participants of the joint session with the Multi-Council Working Group (MCWG) and NEWG, which took place the following day. Next, Saskia Hendriks, MD, PhD, Faculty in the NIH Bioethics Department and National Institute of Neurological Disorders and Stroke (NINDS) Neuroethics Consultant, presented key findings from an analysis on emerging neuroethical considerations in BRAIN grants awarded during fiscal year 2020. Dr. Hendriks summarized 12 themes identified by the analysis, which fell into two broad groups of potential ethical challenges: conducting research ethically; and the implications of research, tools, and technologies on individuals, groups, and society. The NEWG valued these findings, recognizing that the themes were consistent with concurrent discussions of neuroethics priorities for BRAIN. Participants also considered increasing funding opportunity outreach efforts to neuroscientists interested in partnering with neuroethicists. Further, the group acknowledged the need to raise awareness about the value of integrating neuroethics into neuroscience research, potentially by hosting a workshop on identifying ways to facilitate this integration. Henry (Hank) T. Greely, JD, Director of Law and Biosciences at Stanford University and co-chair of the NEWG, led a discussion on potential future NEWG workshop topics for the next phase of the NIH BRAIN Initiative.
    [Show full text]
  • Obama Administration Proposes Over $434 Million in Funding for the BRAIN Initiative
    Obama Administration Proposes Over $434 Million in Funding for the BRAIN Initiative “Last year, I launched the BRAIN Initiative to help unlock the mysteries of the brain, to improve our treatment of conditions like Alzheimer’s and autism and to deepen our understanding of how we think, learn and remember. I’m pleased to announce new steps that my Administration is taking to support this critical research, and I’m heartened to see so many private, philanthropic, and academic institutions joining this effort.” - President Barack Obama September 2014 Since its launch in April 2013, the President’s BRAIN Initiative® - Brain Research through Advancing Innovative Neurotechnologies – has grown to include investments from five Federal agencies: the Defense Advanced Research Projects Agency (DARPA), the National Institutes of Health (NIH), the National Science Foundation (NSF), Intelligence Advanced Research Projects Activity (IARPA), and the Food and Drug Administration (FDA). Federal agencies are supporting the initiative by investing in promising research projects aimed at revolutionizing our understanding of the human brain, developing novel technologies, and supporting further research and development in neurotechnology. The President’s 2017 Budget also proposes funding for the Department of Energy (DOE) to join DARPA, NIH, NSF, IARPA, and FDA in advancing the goals of the BRAIN Initiative. Major foundations, private research institutions, and companies including the Howard Hughes Medical Institute, Allen Institute for Brain Science, the Kavli Foundation, the Simons Foundation, GE, GlaxoSmithKline, as well as patient advocacy organizations and universities, have committed over $500 million to the BRAIN Initiative. There are many opportunities for others across sectors to play a role in this historic initiative through new and expanded commitments to advance the BRAIN Initiative.
    [Show full text]
  • One Page BRAIN Initiative Overview 2018
    ® The BRAIN Initiative Over the past 25 years, the burden of At a glance... neurological disorders has increased sub- stantially. This increase, combined with the Launched in 2013, the NIH BRAIN Initia- growing burden of mental and substance tive is revealing how the brain works, by use disorders, reinforces the need for new developing and applying tools to precise- ways to intervene and deepen our ly map and observe brain circuits. st knowledge of the brain. The 21 Century Cures Act provides NIH Not enough is known about the billions of BRAIN Initiative funding through 2026. brain cells—that communicate via trillions NIH has invested over $950 million in the of synapses to make up the circuitry—that BRAIN Initiative, supporting over 550 enable us to perceive, think, feel, and act. new awards. The Brain Research through Advancing Innovative Neurotechnologies (BRAIN)® Ten NIH Institutes and Centers partici- Initiativewww.braininitiative.org ( ) sup- pate in the NIH BRAIN Initiative. ports research to develop and use extra- The BRAIN Initiative Alliance communi- ordinary new technologies that will revolu- cates BRAIN Initiative activities of Federal tionize our understanding of the brain. agencies and private organizations. 12-Year Scientific Vision • Seven priority areas outline the Initiative: • The BRAIN Multi-Council Working Group (MCWG) helps NIH to track the Initiative and assists with Discovering diversity: Identify different brain informing Advisory Councils of the Institutes and cell types and determine their roles in health Centers that contribute to the NIH BRAIN Initiative. and disease. • The BRAIN Neuroethics Working Group (NEWG) Maps at multiple scales: Generate circuit considers ethical implications arising from the diagrams that vary in resolution from synapses development and use of BRAIN neurotechnologies to the whole brain.
    [Show full text]
  • UNDERSTANDING the BRAIN (Utb) $143,930,000 +$37,490,000 / 35.2%
    UNDERSTANDING THE BRAIN (UtB) $143,930,000 +$37,490,000 / 35.2% Overview Understanding the Brain (UtB) is a multi-year effort that continues the previously titled “Cognitive Science and Neuroscience” activity and that includes NSF’s participation in the Administration’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. For over three decades, NSF has supported fundamental brain research from molecules to cognition and behavior, and enabled technology development, through many disciplinary programs spread across the Foundation. In 2012, Congress encouraged NSF to create a cross-foundation activity in Cognitive Science and Neuroscience, and also encouraged the White House to form an Interagency Working Group on Neuroscience (IWGN) under the National Science and Technology Council, which is co-chaired by NSF. In FY 2013, the President announced the multi-agency BRAIN Initiative, with NSF as one of the lead participating agencies. The Understanding the Brain activity draws together and consolidates NSF’s ongoing activities in Cognitive Science and Neuroscience and the BRAIN Initiative. With UtB, NSF aims to leverage its existing investments and foster greater collaboration among these research and technology disciplines to accelerate fundamental discoveries in neuroscience, cognitive science, and neuroengineering. Understanding the brain is one of the grand scientific challenges at the intersection of the physical, life, behavioral, and engineering sciences. The National Research Council report, “Research at the Intersection of the Physical and Life Sciences” (2010), identified “Understanding the Brain” as one of the top five grand challenges for research that will significantly benefit society. The National Academy of Engineering has also recognized “Reverse-Engineering the Brain” as a Grand Challenge for Engineering (2008).
    [Show full text]
  • Certificate for Approving the Dissertation
    MIAMI UNIVERSITY The Graduate School Certificate for Approving the Dissertation We hereby approve the Dissertation of Kevin J. Rutherford Candidate for the Degree: Doctor of Philosophy Director (Jason Palmeri) Reader (Michele Simmons) Reader (Heidi McKee) Reader (Kate Ronald) Graduate School Representative (Bo Brinkman) ABSTRACT PACK YOUR THINGS AND GO: BRINGING OBJECTS TO THE FORE IN RHETORIC AND COMPOSITION by Kevin J. Rutherford This dissertation project focuses on object-oriented rhetoric (OOR), a perspective that questions the traditional notions of rhetorical action as solely a human province. The project makes three major, interrelated claims: that OOR provides a unique and productive methodology to examine the inclusion of the non-human in rhetorical study; that to some extent, rhetoric has always been interested in the way nonhuman objects interact with humans; and that these claims have profound implications for our activities as teachers and scholars. Chapter one situates OOR within current scholarship in composition and rhetoric, arguing that it can serve as a useful methodology for the field despite rhetoric’s traditional focus on epistemology and human symbolic action. Chapter two examines rhetorical history to demonstrate that a view of rhetoric that includes nonhuman actors is not new, but has often been marginalized. Chapter three examines two videogames as sites of theory and practice for object-oriented rhetoric, specifically focusing on a sense of metaphor to understand the experience of nonhuman rhetors. Chapter four interrogates the network surrounding a review aggregation website to argue that, while some nonhumans may be unhelpful rhetorical collaborators, OOR can assist us in improving relationships with them.
    [Show full text]
  • Genomics on the Brain on 9 September, the Father of the Hydrogen Bomb Passed Away
    2003 in context Neuroscience GOODBYE Edward Teller Genomics on the brain On 9 September, the father of the hydrogen bomb passed away. He was a controversial he 1990s may have been designated the creating transgenic mice that carry these figure, who was vilified by many physicists after T‘Decade of the Brain’,but they will also be BACs,the researchers can identify — by sight testifying in 1954 that Robert Oppenheimer, remembered as the time when genomics — the cells in which a gene of interest is nor- leader of the wartime Manhattan Project, was a came to the fore.This year,neuroscience and mally active,and can work out how these cells security risk. Teller later championed President genomics teamed up in projects that promise connect with the rest of the brain. The same Ronald Reagan’s ‘Star Wars’ missile-defence to propel the study of the brain into the realm BACs can also be used to introduce other initiative. But colleagues at the Lawrence of‘big science’. genetic modifications into these cells,provid- Livermore National Laboratory, co-founded by Working on Parkinson’s disease? One of ing a unique tool to investigate their biology. Teller, say that he should also be remembered the projects that surfaced this year might pro- GENSAT’s first images can already be seen for his passion for teaching physics. vide you with a transgenic mouse that offers on its website,which was launched in October fluorescent neurons in key neural pathways. alongside a paper introducing the project Galileo Another could offer you structural brain (S.
    [Show full text]
  • Understanding the BRAIN NSF's Role in the BRAIN Initiative
    Understanding the Brain: NSF Activities Dr. Amber Story SBE Advisory Committee Deputy Division Director October 31, 2014 Behavioral and Cognitive Sciences Division Computer Social, Biological and Behavioral Sciences Information and Science and Economic Engineering Sciences Education Mathematics and Human and Physical Resources Sciences Geosciences International Engineering and Integrative Activities Focused Programs • Neural Systems and Behavioral Systems Clusters (BIO) • Cognitive Neuroscience and Perception, Action and Cognition Programs (SBE) • Robust Intelligence Program (CISE) Interdisciplinary Programs • Science of Learning Centers (NSF) • Science and Technology Center for Brains, Minds and Machines • Collaborative Research in Computational Neuroscience involving NSF, NIH, Germany, France, Israel Other Significant Investments • Research at the Interface of Biological, Mathematical and Physical Sciences, and Engineering http://nsf.gov/brain NSF's goal is to enable scientific understanding of the full complexity of the brain, in action and in context, through targeted, cross-disciplinary investments in research, technology, and workforce development. Understanding the Brain comprises two NSF-wide activities: Cognitive Science and Neuroscience, initiated in FY 2012 BRAIN Initiative, initiated in FY 2013 • Fostering integrative research that crosses scale, levels of analysis, and disciplines • Expanding investments in innovative technologies, experimental and analytical methods, and data and cyber- infrastructure that will enable
    [Show full text]
  • Neuroplasticity in Children and Adolescents in Response to Cognitive Or Sensory-Motor Interventions
    Reviews/Mini-Reviews Clinical & Translational Neuroscience July-December 2020: 1–21 ª The Author(s) 2020 Neuroplasticity in children and Article reuse guidelines: sagepub.com/journals-permissions DOI: 10.1177/2514183X20974231 adolescents in response to treatment journals.sagepub.com/home/ctn intervention: A systematic review of the literature Lisa L Weyandt1, Christine M Clarkin2,3 , Emily Z Holding4, Shannon E May3, Marisa E Marraccini4, Bergljot Gyda Gudmundsdottir5, Emily Shepard6, and Lauren Thompson3 Abstract The purpose of the present study was to conduct a systematic review of the literature, adhering to PRISMA guidelines, regarding evidence of neuroplasticity in children and adolescents in response to cognitive or sensory-motor interventions. Twenty-eight studies employing seven different types of neuroimaging techniques were included in the review. Findings revealed that significant variability existed across the 28 studies with regard to the clinical populations examined, type of interventions employed, neuroimaging methods, and the type of neuroimaging data included in the studies. Overall, results supported that experience-dependent interventions were associated with neuroplastic changes among children and ado- lescents in both neurotypical and clinical populations. However, it remains unclear whether these molecular neuroplastic changes, including the degree and direction of those differences, were the direct result of the intervention. Although the findings are encouraging, methodological limitations of the studies limit clinical utility of the results. Future studies are warranted that rigorously define the construct of neuroplasticity, establish consistent protocols across measurement techniques, and have adequate statistical power. Lastly, studies are needed to identify the functional and structural neu- roplastic mechanisms that correspond with changes in cognition and behavior in child and adolescent samples.
    [Show full text]
  • NIH Biosketch
    OMB No. 0925-0001 and 0925-0002 (Rev. 09/17 Approved Through 03/31/2020) BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors. Follow this format for each person. DO NOT EXCEED FIVE PAGES. NAME: Ugurbil, Kamil eRA COMMONS USER NAME (credential, e.g., agency login): ugurbil POSITION TITLE: Professor / Director EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add/delete rows as necessary.) DEGREE Completion Date INSTITUTION AND LOCATION FIELD OF STUDY (if applicable) MM/YYYY Columbia University, New York, NY B.A. 1971 Physics Columbia University, New York, NY M.A. 1974 Chemical Physics Columbia University, New York, NY Ph.D. 1977 Chemical Physics A. Personal Statement My research centers around magnetic resonance (MR) imaging and spectroscopy in general, ultrahigh field (UHF) MR methodology and instrumentation in particular, and the use of these methods in biomedical applications, predominantly in the study of brain function. In this area, the team I lead at the Center for Magnetic Resonance Research (CMRR), the University of Minnesota, is internationally recognized for their pioneering contributions, including the introduction of the functional imaging method for imaging brain activity (fMRI), studies aimed at elucidating fMRI mechanisms, the introduction of ultra high magnetic field MR for imaging studies of brain function and neurochemistry in human and animal models, unique applications of UHF techniques in human and animal model studies to achieve for the first time functional maps at the level of neuronal ensembles that represent elementary computational units (e.g.
    [Show full text]
  • BRAIN Initiative Multi-Council Working Group Meeting Summary
    Brain Research through Advancing Innovative Neurotechnologies ® (BRAIN) Multi-Council Working Group (MCWG) Meeting January 31st, 2020 On January 31st, 2020, National Institutes of Health (NIH) Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative Multi-Council Working Group (MCWG) – which ensures coordinated and focused efforts across NIH and provides continuous oversight of the long-term scientific vision of the BRAIN Initiative – met to discuss goals for BRAIN 2.0 (i.e., the second half of the initiative). NIH BRAIN Initiative leaders, the BRAIN Initiative Neuroethics Working Group (NEWG), Intelligence Advanced Research Projects Activity (IARPA), and the Department of Energy (DOE) provided updates and led discussions on current and potential future BRAIN activities. In opening remarks, Walter Koroshetz, MD, Director of the National Institute of Neurological Disorders and Stroke (NINDS) and co-chair of the MCWG, welcomed John Ngai, PhD as the incoming director of the NIH BRAIN Initiative, who is expected to join NIH in March. Dr. Koroshetz then highlighted the success of the initiative, which has been enthusiastically supported by Congress and the NIH. He pointed out that the BRAIN Initiative is now faced with the challenge of ensuring continued productivity. Dr. Ngai introduced himself as the new director of the NIH BRAIN Initiative. He summarized former leadership roles at the University of California, Berkeley, and involvement in the BRAIN Initiative Cell Census Network (BICCN). Dr. Ngai then provided an update on BRAIN 2.0 and discussed his shared vision for the future of the NIH BRAIN Initiative. He outlined strategic goals, such as leveraging advances from BRAIN to enable neuroscience discovery, promoting disease-focused projects, democratizing technologies for scientific and clinical use, and enhancing diversity.
    [Show full text]
  • NINDS Fiscal Year 2021 Congressional Justification
    DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Neurological Disorders and Stroke (NINDS) FY 2021 Budget Page No. Organization Chart ...........................................................................................................................2 Appropriation Language ..................................................................................................................3 Amounts Available for Obligation...................................................................................................4 Budget Mechanism Table ................................................................................................................5 Major Changes in Budget Request ..................................................................................................6 Summary of Changes .......................................................................................................................7 Budget Graphs .................................................................................................................................8 Budget Authority by Activity ..........................................................................................................9 Authorizing Legislation .................................................................................................................10 Appropriations History ..................................................................................................................11 Justification of
    [Show full text]